“Formulation and Optimization of Liquisolid Tablet for Improving the Dissolution Profile of Rivaroxaban by Using DoE Approachand Antithrombic Activity”. 2025. Journal of Carcinogenesis 23 (1): 701-19. https://doi.org/10.64149/J.Carcinog.24.3s.812-830.